Selvita Announces First Patient Dosed in Phase I/II Clinical Trial of SEL24 in Acute Myeloid Leukemia
                
                
                    Kraków, Poland, March 17, 2017 – Selvita (WSE:SLV), a clinical stage drug discovery and development company focused on innovative medicines for patients…